Evidence map›Paper›PMID 21991404›Full record

ArticleJournal of lipids2012

Bile Acid signaling in liver metabolism and diseases.

Tiangang Li, John Y L Chiang

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipids, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 153 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Secondary bile acids are associated with body lipid accumulation in obese pigs.Animal nutrition (Zhongguo xu mu shou yi xue hui) · 2024
    Article
  10. Unravelling the therapeutic landscape of bile acid-based therapies in gastrointestinal disorders.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association · 2024
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Tiangang LiDepartment of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, Ohio, OH 44272, USA.
John Y L Chiang
Northeast Ohio Medical University · US

Funding

MOLECULAR BIOLOGY OF BILE ACID SYNTHESISR01DK044442 · NIDDK · NORTHEAST OHIO MEDICAL UNIVERSITY · PI FERRELL, JESSICA MARIE · 1994 to 2022
$5.9M
Regulation of Bile Acid Synthesis by Nuclear ReceptorsR37DK058379 · NIDDK · NORTHEAST OHIO MEDICAL UNIVERSITY · PI CHIANG, JOHN Y. L. · 2011 to 2020
$3.6M
Regulation of Bile Acid Synthesis by Nuclear ReceptorsR01DK058379 · NIDDK · NORTHEAST OHIO MEDICAL UNIVERSITY · PI CHIANG, JOHN Y. L. · 2002 to 2010
$2.6M
Molecular Biology of Bile Acid SynthesisR56DK044442 · NIDDK · NORTHEAST OHIO MEDICAL UNIVERSITY · PI CHIANG, JOHN Y. L. · 2009 to 2009
$379k
NIDDK NIH HHS R01 DK044442NIDDK NIH HHS R01 DK058379NIDDK NIH HHS R37 DK058379NIDDK NIH HHS R56 DK044442
6 · The paper itself

Abstract

Obesity, diabetes, and metabolic syndromes are increasingly recognized as health concerns worldwide. Overnutrition and insulin resistance are the major causes of diabetic hyperglycemia and hyperlipidemia in humans. Studies in the past decade provide evidence that bile acids are not just biological detergents facilitating gut nutrient absorption, but also important metabolic regulators of glucose and lipid homeostasis. Pharmacological alteration of bile acid metabolism or bile acid signaling pathways such as using bile acid receptor agonists or bile acid binding resins may be a promising therapeutic strategy for the treatment of obesity and diabetes. On the other hand, bile acid signaling is complex, and the molecular mechanisms mediating the bile acid effects are still not completely understood. This paper will summarize recent advances in our understanding of bile acid signaling in regulation of glucose and lipid metabolism, and the potentials of developing novel therapeutic strategies that target bile acid metabolism for the treatment of metabolic disorders.

Identifiers

PMID21991404
PMCPMC3185234
OpenAlexW2066196011

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.